Loading clinical trials...
Loading clinical trials...
Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema and Retinal Vein Occlusion Patients
Conditions
Interventions
Intravitreal injection of aflibercept 8 mg
Locations
1
Egypt
faculty of medicine, Tanta University
Tanta, Egypt
Start Date
October 19, 2025
Primary Completion Date
November 19, 2025
Completion Date
December 19, 2025
Last Updated
March 17, 2025
NCT07308639
NCT07449936
NCT07449923
NCT07133438
NCT07228559
NCT06929143
Lead Sponsor
Tanta University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions